Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men

American Journal of Cardiology

Volumn 95, Issue 7, 2005, Pages 865-868

  Desai, Milind Y ^b   Santos, Raul D ^b   Dalal, Darshan ^b   Carvalho, Jose A M ^b   Martin, Don R ^b   Flynn, John A ^b   Nasir, Khurram ^b   Blumenthal, Roger S ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

AGED; ARTICLE; CONTROLLED STUDY; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLISM; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 15244356856     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.013     Document Type: Article

References (20)

1. W. Rathmann, E. Funkhouser, A.R. Dyer, J.M. Roseman Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study Coronary Artery Risk Development in Young Adults Ann Epidemiol 8 1998 250 261
2. D. Conen, V. Wietlisbach, P. Bovet, C. Shamlaye, W. Riesen, F. Paccaud, M. Burnier Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country BMC Public Health 4 2004 9
3. A.R. Folsom, G.L. Burke, C. Ballew, D.R. Jacobs Jr, W.L. Haskell, R.P. Donahue, K.A. Liu, J.E. Hilner Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites The role of insulin Am J Epidemiol 130 1989 911 924
4. J. Lee, D. Sparrow, P.S. Vokonas, L. Landsberg, S.T. Weiss Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome The Normative Aging Study Am J Epidemiol 142 1995 288 294
5. J.V. Selby, G.D. Friedman, C.P. Quesenberry Jr Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries Am J Epidemiol 131 1990 1017 1027
6. H. Vuorinen-Markkola, H. Yki-Jarvinen Hyperuricemia and insulin resistance J Clin Endocrinol Metab 78 1994 25 29
7. V.V. Salomaa, J. Tuomilehto, M. Jauhiainen, H.J. Korhonen, J. Stengard, M. Uusitupa, M. Pitkanen, I. Penttila Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study Diabetes Care 15 1992 657 665
8. M. Modan, H. Halkin, A. Karasik, A. Lusky Elevated serum uric acid--a facet of hyperinsulinaemia Diabetologia 30 1987 713 718
9. R.J. Kuczmarski, M.D. Carroll, K.M. Flegal, R.P. Troiano Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994) Obes Res 5 1997 542 548
10. I. Zavaroni, L. Bonini, M. Fantuzzi, E. Dall'Aglio, M. Passeri, G.M. Reaven Hyperinsulinaemia, obesity, and syndrome X J Intern Med 235 1994 51 56
11. T. McLaughlin, F. Abbasi, M. Carantoni, P. Schaaf, G. Reaven Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women J Clin Endocrinol Metab 84 1999 578 581
12. T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, G. Reaven Use of metabolic markers to identify overweight individuals who are insulin resistant Ann Intern Med 139 2003 802 809
13. B.C. Solymoss, M.G. Bourassa, L. Campeau, A. Sniderman, M. Marcil, J. Lesperance, S. Levesque, S. Varga Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity Am J Cardiol 93 2004 159 164
14. M. Alderman, K.J. Aiyer Uric acid: role in cardiovascular disease and effects of losartan Curr Med Res Opin 20 2004 369 379
15. Z. Tsutsumi, Y. Moriwaki, S. Takahashi, T. Ka, T. Yamamoto Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy Clin Chim Acta 339 2004 117 122
16. D.I. Feig, T. Nakagawa, S.A. Karumanchi, W.J. Oliver, D.H. Kang, J. Finch, R.J. Johnson Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension Kidney Int 66 2004 281 287
17. V.G. Athyros, M. Elisaf, A.A. Papageorgiou, A.N. Symeonidis, A.N. Pehlivanidis, V.I. Bouloukos, H.J. Milionis, D.P. Mikhailidis Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study Am J Kidney Dis 43 2004 589 599
18. F. Youssef, P. Gupta, A.M. Seifalian, F. Myint, D.P. Mikhailidis, G. Hamilton The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease Angiology 55 2004 53 62
19. B.F. Becker, N. Reinholz, B. Leipert, P. Raschke, B. Permanetter, E. Gerlach Role of uric acid as an endogenous radical scavenger and antioxidant Chest 100 1991 176S 181S
20. K. Nyyssonen, E. Porkkala-Sarataho, J. Kaikkonen, J.T. Salonen Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men Atherosclerosis 130 1997 223 233